197 related articles for article (PubMed ID: 1416884)
1. Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia.
Walzer PD; Foy J; Steele P; Kim CK; White M; Klein RS; Otter BA; Allegra C
Antimicrob Agents Chemother; 1992 Sep; 36(9):1935-42. PubMed ID: 1416884
[TBL] [Abstract][Full Text] [Related]
2. Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
Walzer PD; Foy J; Steele P; White M
Antimicrob Agents Chemother; 1993 Jul; 37(7):1436-43. PubMed ID: 8363372
[TBL] [Abstract][Full Text] [Related]
3. Low-dose trimethoprim-sulfamethoxazole alone and in association with zidovudine for prevention and treatment of murine Pneumocystis carinii pneumonia.
Brun-Pascaud M; Girard PM; Pocidalo JJ
Antimicrob Agents Chemother; 1992 Oct; 36(10):2328-30. PubMed ID: 1444313
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of trimetrexate, a potent lipid-soluble antifolate, in the treatment of rodent Pneumocystis carinii pneumonia.
Kovacs JA; Allegra CJ; Kennedy S; Swan JC; Drake J; Parrillo JE; Chabner B; Masur H
Am J Trop Med Hyg; 1988 Nov; 39(5):491-6. PubMed ID: 2973755
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.
Walzer PD; Kim CK; Foy JM; Linke MJ; Cushion MT
Antimicrob Agents Chemother; 1988 Jan; 32(1):96-103. PubMed ID: 3258144
[TBL] [Abstract][Full Text] [Related]
6. Altered trimethoprim-sulfamethoxazole ratios for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii dual infections in rat model.
Brun-Pascaud M; Chau F; Garry L; Farinotti R; Derouin F; Girard PM
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):201-7. PubMed ID: 8898664
[TBL] [Abstract][Full Text] [Related]
7. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.
Fisher RG; Nageswaran S; Valentine ME; McKinney RE
AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activity of iclaprim, a diaminopyrimidine compound and potential therapeutic alternative against Pneumocystis pneumonia.
Aliouat EM; Dei-Cas E; Gantois N; Pottier M; Pinçon C; Hawser S; Lier A; Huang DB
Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):409-415. PubMed ID: 29330709
[TBL] [Abstract][Full Text] [Related]
10. Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in AIDS patients with previous allergic reactions.
Shafer RW; Seitzman PA; Tapper ML
J Acquir Immune Defic Syndr (1988); 1989; 2(4):389-93. PubMed ID: 2526871
[TBL] [Abstract][Full Text] [Related]
11. Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.
Hughes WT; Killmar J
Antimicrob Agents Chemother; 1996 Apr; 40(4):962-5. PubMed ID: 8849260
[TBL] [Abstract][Full Text] [Related]
12. Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
Brun-Pascaud M; Chau F; Garry L; Jacobus D; Derouin F; Girard PM
Antimicrob Agents Chemother; 1996 Sep; 40(9):2067-70. PubMed ID: 8878582
[TBL] [Abstract][Full Text] [Related]
13. Employment of terbinafine against Pneumocystis carinii infection in rat models.
Contini C; Colombo D; Cultrera R; Prini E; Sechi T; Angelici E; Canipari R
Br J Dermatol; 1996 Jun; 134 Suppl 46():30-2; discussion 40. PubMed ID: 8763466
[TBL] [Abstract][Full Text] [Related]
14. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
Carr A; Tindall B; Penny R; Cooper DA
AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
[TBL] [Abstract][Full Text] [Related]
16. Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
Hughes WT
Antimicrob Agents Chemother; 1988 May; 32(5):623-5. PubMed ID: 3260765
[TBL] [Abstract][Full Text] [Related]
17. Failure of trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis carinii pneumonia with concurrent leucovorin use.
Razavi B; Lund B; Allen BL; Schlesinger L
Infection; 2002 Jan; 30(1):41-2. PubMed ID: 11876516
[TBL] [Abstract][Full Text] [Related]
18. Limited effect of trimethoprim-sulfamethoxazole prophylaxis on Pneumocystis carinii.
Hughes WT
Antimicrob Agents Chemother; 1979 Sep; 16(3):333-5. PubMed ID: 315754
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Pneumocystis carinii dihydropteroate synthetase by para-acetamidobenzoic acid: possible mechanism of action of isoprinosine in human immunodeficiency virus infection.
Kovacs JA; Powell F; Voeller D; Allegra CJ
Antimicrob Agents Chemother; 1993 Jun; 37(6):1227-31. PubMed ID: 7687120
[TBL] [Abstract][Full Text] [Related]
20. [Infection prophylaxis in patients with hematological malignancies (I)--Successful prophylaxis of Pneumocystis carinii pneumonitis with sulfamethoxazole-trimethoprim].
Moriuchi Y; Kamihira S; Satoh T; Yanagisako T; Miyazaki Y; Nagai K; Murata K; Tokunaga S; Maeda T; Atogami S
Rinsho Ketsueki; 1990 Nov; 31(11):1818-22. PubMed ID: 2287067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
